A 67-year-old man with benign prostatic hyperplasia is newly diagnosed. Which medication is most appropriate for first-line treatment?

A 67-year-old man with benign prostatic hyperplasia is newly diagnosed. Which medication is most appropriate for first-line treatment?

• A. Finasteride 5 mg daily.
• B. Tamsulosin 400 micrograms once daily.
• C. Doxazosin.
• D. Tadalafil 10 mg daily.

Answer: (B)

When starting treatment for bothersome lower urinary tract symptoms from BPH, the goal is rapid relief of obstruction with minimal systemic side effects, especially in an older patient. An alpha-1 blocker that is selective for the prostatic smooth muscle fits this best. Tamsulosin targets alpha-1A receptors in the prostate and bladder neck, relaxing the smooth muscle there and improving urine flow quickly—often within days to a couple of weeks. It also tends to cause less blood pressure drop than non-selective alpha-1 blockers, which is important in a 67-year-old who may be at risk for falls or dizziness. Finasteride works by shrinking the prostate over months by inhibiting conversion of testosterone to dihydrotestosterone, so its onset is slow and it’s more suited to men with larger glands or higher PSA, not as a first-line for immediate symptom relief. A non-selective alpha-1 blocker like doxazosin can help but carries a higher risk of orthostatic hypotension and dizziness, which is less desirable in older patients. PDE-5 inhibitors like tadalafil can help with BPH symptoms and erectile dysfunction, but they aren’t the first-line choice when rapid symptomatic relief is desired and the patient doesn’t have concurrent ED. So, starting with tamsulosin at a typical 0.4 mg once daily provides quick symptom relief with a favorable safety profile, making it the most appropriate first-line option.

When starting treatment for bothersome lower urinary tract symptoms from BPH, the goal is rapid relief of obstruction with minimal systemic side effects, especially in an older patient. An alpha-1 blocker that is selective for the prostatic smooth muscle fits this best. Tamsulosin targets alpha-1A receptors in the prostate and bladder neck, relaxing the smooth muscle there and improving urine flow quickly—often within days to a couple of weeks. It also tends to cause less blood pressure drop than non-selective alpha-1 blockers, which is important in a 67-year-old who may be at risk for falls or dizziness.

Finasteride works by shrinking the prostate over months by inhibiting conversion of testosterone to dihydrotestosterone, so its onset is slow and it’s more suited to men with larger glands or higher PSA, not as a first-line for immediate symptom relief. A non-selective alpha-1 blocker like doxazosin can help but carries a higher risk of orthostatic hypotension and dizziness, which is less desirable in older patients. PDE-5 inhibitors like tadalafil can help with BPH symptoms and erectile dysfunction, but they aren’t the first-line choice when rapid symptomatic relief is desired and the patient doesn’t have concurrent ED.

So, starting with tamsulosin at a typical 0.4 mg once daily provides quick symptom relief with a favorable safety profile, making it the most appropriate first-line option.